Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie’s Disease

Marcon, Julian; Stief, Christian G.

doi:10.1007/978-3-030-28599-9_21

Urologic Principles and Practice 2020

DOI: 10.1007/978-3-030-28599-9_21

|View full text |Cite

Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie’s Disease

Julian Marcon¹,

Christian G. Stief²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

Publication Types

Select...

Article1

Relationship

Self Cite1

Independent0

Authors

Journals

Cited by 1 publication

References 192 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Impact of antiangiogenic treatment on the erectile function in patients with advanced renal cell carcinoma

et al. 2020

Self Cite

View full text Add to dashboard Cite

Sexual function, including erectile function in men, is increasingly moving into the foreground in the care of patients with renal cell carcinoma (RCC). Historically, metastatic RCC had a rather poor prognosis, due to ineffective therapies, with a median overall survival of approximately 1 year (Motzer et al., 2007). The advent of targeted agents over a decade ago has dramatically improved survival and quality of life (QoL) in patients with advanced disease (Hsieh et al., 2017). Systemic treatment in advanced RCC patients usually comprises multiple sequential treatment lines including antiangiogenic therapy (AAT), most commonly inhibitors of tyrosine kinases (TKI) or the mammalian target of rapamycin (mTOR-inh). In addition, immune checkpoint inhibitors were recently approved for the treatment of metastatic kidney cancer (Hsieh et al., 2017). The effect of AAT on sexuality and erectile function in patients with RCC has been addressed in prior studies. A recent longitudinal study including both men and women described a decrease in several

show abstract

Impact of antiangiogenic treatment on the erectile function in patients with advanced renal cell carcinoma

et al. 2020

Self Cite

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie’s Disease

Cited by 1 publication

References 192 publications

Impact of antiangiogenic treatment on the erectile function in patients with advanced renal cell carcinoma

Impact of antiangiogenic treatment on the erectile function in patients with advanced renal cell carcinoma

Contact Info

Product

Resources

About